Article Text

other Versions

PDF
Extended report
A prediction rule for the development of arthritis in seropositive arthralgia patients
  1. Lotte Arwen van de Stadt1,
  2. Birgit I Witte2,
  3. Wouter H Bos1,
  4. Dirkjan van Schaardenburg1,3
  1. 1Department of Rheumatology, Jan van Breemen Research Institute|Reade, Amsterdam, The Netherlands
  2. 2Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands
  3. 3VU Universitiy Medical center, Department of Rheumatology, Amsterdam, The Netherlands
  1. Correspondence to Lotte Arwen van de Stadt, Jan van Breemen Research Institute|Reade, PO Box 58271, 1040 HG Amsterdam 1056AB, The Netherlands; l.vd.stadt{at}reade.nl

Abstract

Objective To predict the development of arthritis in anticyclic citrullinated peptide antibodies and/or IgM rheumatoid factor positive (seropositive) arthralgia patients.

Methods A prediction rule was developed using a prospective cohort of 374 seropositive arthralgia patients, followed for the development of arthritis. The model was created with backward stepwise Cox regression with 18 variables.

Results 131 patients (35%) developed arthritis after a median of 12 months. The prediction model consisted of nine variables: Rheumatoid Arthritis in a first degree family member, alcohol non-use, duration of symptoms <12 months, presence of intermittent symptoms, arthralgia in upper and lower extremities, visual analogue scale pain ≥50, presence of morning stiffness ≥1 h, history of swollen joints as reported by the patient and antibody status. A simplified prediction rule was made ranging from 0 to 13 points. The area under the curve value (95% CI) of this prediction rule was 0.82 (0.75–0.89) after 5 years. Harrell's C (95% CI) was 0.78 (0.73–0.84). Patients could be categorised in three risk groups: low (0–4 points), intermediate (5–6 points) and high risk (7–13 points). With the low risk group as a reference, the intermediate risk group had a hazard ratio (HR; 95% CI) of 4.52 (2.42–8.77) and the high risk group had a HR of 14.86 (8.40–28.32).

Conclusions In patients presenting with seropositive arthralgia, the risk of developing arthritis can be predicted. The prediction rule that was made in this patient group can help (1) to inform patients and (2) to select high-risk patients for intervention studies before clinical arthritis occurs.

  • Rheumatoid Arthritis
  • Autoantibodies
  • Early Rheumatoid Arthritis
  • Epidemiology

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.